Harvard Apparatus Regenerative Technology,
Why Robinhood?
You can watch HRGN and buy or sell other stocks, ETFs, and their options commission-free!About HRGN
Harvard Apparatus Regenerative Technology, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function.
HRGN Key Statistics
Stock Snapshot
The current Harvard Apparatus Regenerative Technology,(HRGN) stock price is $1.85, with a market capitalization of 31.76M. The stock trades at a price-to-earnings (P/E) ratio of -4.59.
As of 2025-12-07, Harvard Apparatus Regenerative Technology,(HRGN) stock has fluctuated between $1.65 and $2.00. The current price stands at $1.85, placing the stock +12.1% above today's low and -7.5% off the high.
Harvard Apparatus Regenerative Technology,(HRGN) shares are trading with a volume of 16.74K, against a daily average of 6.62K.
In the last year, Harvard Apparatus Regenerative Technology,(HRGN) shares hit a 52-week high of $3.19 and a 52-week low of $0.94.
In the last year, Harvard Apparatus Regenerative Technology,(HRGN) shares hit a 52-week high of $3.19 and a 52-week low of $0.94.